🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Adaptive Biotechnologies Corporation

ADPT Healthcare
$25.49 +$0.93 (3.79%)
Market Cap: $4.07 B
Gurus Holding
7
Popularity Rank
#1047
% of Shares Held
20.93%
Net Activity (Q2 2026)
-$22.13 M

Guru Ownership Trend

Guru Analysis for Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Corporation (ADPT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $851.57 M.

Top institutional holders include Andreas Halvorsen and Catherine Wood.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $22.13 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 26.3%. Conversely, Ray Dalio reduced exposure by 55.3%.

Key Holders

Recent Activity Breakdown (Q2 2026)

+$1.35 M
Total Buy Value
New Buys 0
Additions 1
-$23.48 M
Total Sell Value
Reductions 5
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
6
Net Buyers
1

FAQs for Adaptive Biotechnologies Corporation (ADPT)

Major holders include Andreas Halvorsen ($643.37 M), Catherine Wood ($44.84 M), Paul Tudor Jones ($11.66 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 33.41 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $22.13 M, with 1 managers increasing positions and 6 managers reducing holdings.

During the most recent reporting period, 5 managers trimmed their positions, while 1 fully exited ADPT. The total reported sell value was $23.48 M.

Yes, 0 managers opened new positions in ADPT, and 1 increased their existing holdings. The total reported buy value was $1.35 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.83% 29,993,708 $643.37 M Q2 2026
0.29% Reduce -0.1% 2,090,306 $44.84 M Q2 2026
0.02% Reduce -30.9% 543,485 $11.66 M Q2 2026
0.00% Reduce -25.2% 362,916 $7.78 M Q2 2026
0.01% Add 26.3% 302,800 $6.5 M Q2 2026
0.00% Reduce -17.7% 74,732 $1.6 M Q2 2026
0.00% Reduce -55.3% 40,087 $859,866 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form